The shaping and functional consequences of the microRNA landscape in breast cancer
- PMID: 23644459
- DOI: 10.1038/nature12108
The shaping and functional consequences of the microRNA landscape in breast cancer
Abstract
MicroRNAs (miRNAs) show differential expression across breast cancer subtypes, and have both oncogenic and tumour-suppressive roles. Here we report the miRNA expression profiles of 1,302 breast tumours with matching detailed clinical annotation, long-term follow-up and genomic and messenger RNA expression data. This provides a comprehensive overview of the quantity, distribution and variation of the miRNA population and provides information on the extent to which genomic, transcriptional and post-transcriptional events contribute to miRNA expression architecture, suggesting an important role for post-transcriptional regulation. The key clinical parameters and cellular pathways related to the miRNA landscape are characterized, revealing context-dependent interactions, for example with regards to cell adhesion and Wnt signalling. Notably, only prognostic miRNA signatures derived from breast tumours devoid of somatic copy-number aberrations (CNA-devoid) are consistently prognostic across several other subtypes and can be validated in external cohorts. We then use a data-driven approach to seek the effects of miRNAs associated with differential co-expression of mRNAs, and find that miRNAs act as modulators of mRNA-mRNA interactions rather than as on-off molecular switches. We demonstrate such an important modulatory role for miRNAs in the biology of CNA-devoid breast cancers, a common subtype in which the immune response is prominent. These findings represent a new framework for studying the biology of miRNAs in human breast cancer.
Similar articles
-
Identification of Novel Breast Cancer Subtype-Specific Biomarkers by Integrating Genomics Analysis of DNA Copy Number Aberrations and miRNA-mRNA Dual Expression Profiling.Biomed Res Int. 2015;2015:746970. doi: 10.1155/2015/746970. Epub 2015 Apr 15. Biomed Res Int. 2015. PMID: 25961039 Free PMC article.
-
Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control.BMC Genomics. 2013 Sep 23;14:643. doi: 10.1186/1471-2164-14-643. BMC Genomics. 2013. PMID: 24059244 Free PMC article.
-
Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer.Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7413-7. doi: 10.1073/pnas.1304977110. Epub 2013 Apr 15. Proc Natl Acad Sci U S A. 2013. PMID: 23589849 Free PMC article.
-
MicroRNA involvement in the pathogenesis and management of breast cancer.J Clin Pathol. 2009 May;62(5):422-8. doi: 10.1136/jcp.2008.060681. J Clin Pathol. 2009. PMID: 19398594 Review.
-
Small players with big roles: microRNAs as targets to inhibit breast cancer progression.Curr Drug Targets. 2010 Sep;11(9):1059-73. doi: 10.2174/138945010792006762. Curr Drug Targets. 2010. PMID: 20545613 Free PMC article. Review.
Cited by
-
MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells.Oncogene. 2015 Jul 23;34(30):3895-907. doi: 10.1038/onc.2014.430. Epub 2014 Dec 22. Oncogene. 2015. PMID: 25531331
-
The microRNA target site landscape is a novel molecular feature associating alternative polyadenylation with immune evasion activity in breast cancer.Brief Bioinform. 2021 May 20;22(3):bbaa191. doi: 10.1093/bib/bbaa191. Brief Bioinform. 2021. PMID: 32844230 Free PMC article.
-
miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.Cell Death Dis. 2016 Jun 30;7(6):e2291. doi: 10.1038/cddis.2016.194. Cell Death Dis. 2016. PMID: 27362808 Free PMC article.
-
Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab.Cancers (Basel). 2022 Sep 28;14(19):4739. doi: 10.3390/cancers14194739. Cancers (Basel). 2022. PMID: 36230658 Free PMC article.
-
Direct Transcriptional Consequences of Somatic Mutation in Breast Cancer.Cell Rep. 2016 Aug 16;16(7):2032-46. doi: 10.1016/j.celrep.2016.07.028. Epub 2016 Aug 4. Cell Rep. 2016. PMID: 27498871 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical